Stealthy Anexon raises $7M for heart disease tech
Stealthy cardiovascular biotech Anexon Inc. reports it has raised $7 million in new venture financing, naming the prestigious Mayo Clinic as an investor.
On Tuesday, the Cambridge company filed three separate documents with the U.S. Securities and Exchange Commission, reporting fundraises of $2 million, $3 million and $2 million again. The last $2 million is part of a planned $12 million round, the company reported. It was not clear whether the investments were concurrent, or had come separately in the three years since Anexon was founded with a reported $500,000 in seed money from Cambridge life sciences venture firm Healthcare Ventures.